ELYMUCO
associated with 10 other trademarks
Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, t...

Words that describe this trademark:

pharmaceutical biotechnology  substances  medication  preparations  biotechnology 

Serial Number:

88705126

Mark:

ELYMUCO

Status:

Abandoned-No Statement of Use filed

Status Date:

02-12-2024

Filing Date:

Registration Number:

N/A

Registration Date:

N/A

Goods and Services:

Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection

Mark Description:

N/A

Class:

Pharmaceutical and veterinary preparations

Type of Mark:

Trademark

Published for Opposition Date:

11-17-2020

Mark Drawing Status:

Standart Character Mark

Abandon Date:

02-12-2024

Business Name:

STERNE, KESSLER, GOLDSTEIN & FOX, P.L.L.

Correspondent Name:

Recent Trademark filings by this company